Clinical Trial Update: Role of Oral Zinc in Reducing Neonatal Indirect Hyperbilirubinemia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether oral zinc reduces neonatal indirect hyperbilirubinemia in neonatal jaundice has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Jaundice

Drugs mentioned

• ZINC (Zinc chloride)

Snippet

Sponsor: National Liver Institute, Egypt | Conditions: Neonatal Jaundice | Phase 3 | Status: COMPLETED